Analysts See $0.44 EPS for Novozymes A/S (NVZMY); Shorts at Ncs Multistage Holdings (NCSM) Raised By 32.85%

April 12, 2018 - By Marie Mckinney

Novozymes A/S (OTCMKTS:NVZMY) Logo

Analysts expect Novozymes A/S (OTCMKTS:NVZMY) to report $0.44 EPS on April, 25.They anticipate $0.07 EPS change or 18.92% from last quarter’s $0.37 EPS. NVZMY’s profit would be $127.80 million giving it 29.14 P/E if the $0.44 EPS is correct. After having $0.43 EPS previously, Novozymes A/S’s analysts see 2.33% EPS growth. The stock increased 0.49% or $0.25 during the last trading session, reaching $51.28. About shares traded. Novozymes A/S (OTCMKTS:NVZMY) has 0.00% since April 12, 2017 and is . It has underperformed by 11.55% the S&P500.

Ncs Multistage Holdings Inc (NASDAQ:NCSM) had an increase of 32.85% in short interest. NCSM’s SI was 1.23 million shares in April as released by FINRA. Its up 32.85% from 925,600 shares previously. With 164,300 avg volume, 8 days are for Ncs Multistage Holdings Inc (NASDAQ:NCSM)’s short sellers to cover NCSM’s short positions. The SI to Ncs Multistage Holdings Inc’s float is 14.21%. The stock increased 4.23% or $0.71 during the last trading session, reaching $17.49. About 50,964 shares traded. NCS Multistage Holdings, Inc. (NASDAQ:NCSM) has 0.00% since April 12, 2017 and is . It has underperformed by 11.55% the S&P500.

NCS Multistage Holdings, Inc. provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States and internationally. The company has market cap of $778.01 million. The companyÂ’s products include casing-installed sliding sleeves, downhole frac isolation assemblies, airlock casing buoyancy systems, liner hanger systems, sand jet perforating products, spotfrac systems, and ballshift sliding sleeves. It has a 364.38 P/E ratio. It also provides advisory services to clients on completion creates and field development strategies.

Among 6 analysts covering Novozymes (OTCMKTS:NVZMY), 1 have Buy rating, 1 Sell and 4 Hold. Therefore 17% are positive. Novozymes had 10 analyst reports since August 7, 2015 according to SRatingsIntel. Jefferies maintained the shares of NVZMY in report on Wednesday, October 25 with “Hold” rating. The rating was upgraded by Goldman Sachs on Wednesday, January 20 to “Neutral”. JP Morgan upgraded the stock to “Overweight” rating in Friday, December 9 report. The firm has “Neutral” rating given on Friday, February 10 by JP Morgan. Berenberg initiated the stock with “Sell” rating in Tuesday, September 27 report. The firm earned “Hold” rating on Monday, August 14 by Jefferies. The rating was downgraded by Nordea to “Hold” on Friday, August 7. Bernstein upgraded the stock to “Outperform” rating in Thursday, January 5 report. The firm earned “Sell” rating on Monday, October 12 by Goldman Sachs. The firm has “Buy” rating given on Friday, August 7 by Nordea.

Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company has market cap of $14.89 billion. It operates in three divisions: Household Care & Technical, Agriculture & Bioenergy, and Food & Beverages. It has a 29.59 P/E ratio. The firm offers enzymes for use in household care products, such as laundry detergents, hand and automatic dishwashing soaps, and professional cleaning products.

NCS Multistage Holdings, Inc. (NASDAQ:NCSM) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>